These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 35093626)

  • 41. Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines.
    Hwang J; Lee SB; Lee SW; Lee MH; Koyanagi A; Jacob L; Tizaoui K; Yon DK; Shin JI; Smith L
    J Autoimmun; 2021 Aug; 122():102681. PubMed ID: 34139631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low clinical utility of testing for anti-platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV-19 vaccine.
    Barefah AS; Radhwi OO; Alamri SS; Alahwal HM; Denetiu I; Almohammadi AT; Bahashwan SM; Qari MH; Algaissi A; Alamer E; Alhazmi A; Abuzenadah AM; Nasraldeen WH; Alzahrani SH; Hashem AM
    Int J Lab Hematol; 2022 Apr; 44(2):424-429. PubMed ID: 34850575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature.
    Cascio Rizzo A; Giussani G; Agostoni EC
    Cerebrovasc Dis; 2022; 51(6):722-734. PubMed ID: 35512656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases.
    Cleaver J; Ibitoye R; Morrison H; Flood R; Crewdson K; Marsh A; Abhinav K; Bosnell R; Crossley R; Mortimer A
    J Neurointerv Surg; 2022 Sep; 14(9):853-857. PubMed ID: 34782400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Greinacher A; Schönborn L; Siegerist F; Steil L; Palankar R; Handtke S; Reder A; Thiele T; Aurich K; Methling K; Lalk M; Völker U; Endlich N
    Semin Hematol; 2022 Apr; 59(2):97-107. PubMed ID: 35512907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis.
    Schönborn L; Seck SE; Thiele T; Kaderali L; Hoffmann T; Hlinka A; Lindhoff-Last E; Völker U; Selleng K; Buoninfante A; Cavaleri M; Greinacher A
    J Thromb Haemost; 2023 Sep; 21(9):2519-2527. PubMed ID: 37394120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.
    Hviid A; Hansen JV; Thiesson EM; Wohlfahrt J
    Ann Intern Med; 2022 Apr; 175(4):541-546. PubMed ID: 35103482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Understanding vaccine-induced thrombotic thrombocytopenia (VITT).
    Dix C; McFadyen J; Huang A; Chunilal S; Chen V; Tran H
    Intern Med J; 2022 May; 52(5):717-723. PubMed ID: 35446471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis.
    Graf T; Thiele T; Klingebiel R; Greinacher A; Schäbitz WR; Greeve I
    J Neurol; 2021 Dec; 268(12):4483-4485. PubMed ID: 34023956
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management].
    Walter U; Volmer E; Wittstock M; Storch A; Weber MA; Großmann A
    Radiologe; 2021 Oct; 61(10):923-932. PubMed ID: 34327553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study.
    Perry RJ; Tamborska A; Singh B; Craven B; Marigold R; Arthur-Farraj P; Yeo JM; Zhang L; Hassan-Smith G; Jones M; Hutchcroft C; Hobson E; Warcel D; White D; Ferdinand P; Webb A; Solomon T; Scully M; Werring DJ; Roffe C;
    Lancet; 2021 Sep; 398(10306):1147-1156. PubMed ID: 34370972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombus Distribution in Vaccine-induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    Rogers P; Walker I; Yeung J; Khan A; Gangi A; Mobashwera B; Ayto R; Shah A; Hermans J; Murchison A; Benger M; Apap Mangion S; Mehta PR; Sztriha L; Ghatorae S; Craven B; Scully M; Bray T; Hall-Craggs M; von Stempel C;
    Radiology; 2022 Dec; 305(3):590-596. PubMed ID: 35699579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Gabarin N; Arnold DM; Nazy I; Warkentin TE
    Semin Hematol; 2022 Apr; 59(2):89-96. PubMed ID: 35512906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    Ostrowski SR; Søgaard OS; Tolstrup M; Stærke NB; Lundgren J; Østergaard L; Hvas AM
    Front Immunol; 2021; 12():779453. PubMed ID: 34887867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccine-induced immune thrombotic thrombocytopenia with atypical vein thrombosis: Implications for clinical practice.
    Zamboni P; Scerrati A; Sessa F; Pomara C; Mannucci PM
    Phlebology; 2022 Apr; 37(3):180-187. PubMed ID: 35068258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations.
    Lavin M; Elder PT; O'Keeffe D; Enright H; Ryan E; Kelly A; El Hassadi E; McNicholl FP; Benson G; Le GN; Byrne M; Ryan K; O'Connell NM; O'Donnell JS
    Br J Haematol; 2021 Oct; 195(1):76-84. PubMed ID: 34159588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccine in an older patient: Minireview and a case report.
    Luciano PQ; Binatti R; Sodré AR; Zajac SR; Marson FAL; Ortega MM
    J Infect Public Health; 2022 Jun; 15(6):638-642. PubMed ID: 35580449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebral venous sinus thrombosis after adenovirus-vectored COVID-19 vaccination: review of the neurological-neuroradiological procedure.
    Wittstock M; Walter U; Volmer E; Storch A; Weber MA; Großmann A
    Neuroradiology; 2022 May; 64(5):865-874. PubMed ID: 35184205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arterial intracranial thrombosis as the first manifestation of vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report.
    Mancuso M; Lauretti DL; Cecconi N; Santini M; Lami V; Orlandi G; Casagli S; Ghetta A; Liberti G; Elena BM; Siciliano G; Cosottini M
    Neurol Sci; 2022 Mar; 43(3):2085-2089. PubMed ID: 35022931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune Thrombocytopenia and Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Case Report.
    Kataria S; Reza RR; Agboola AA; Mohamed KH; Mohamed AS; Zahid N; Haseeb M; Nasir H
    Cureus; 2023 Jan; 15(1):e34272. PubMed ID: 36855477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.